Analysis of the autoimmune response to BP180 in Chinese stroke patients

Abstract Background Significant association between bullous pemphigoid (BP) and stroke has been reported. This study aimed to evaluate the level of anti-BP180 antibody in stroke patients to explore the relationship between BP and stroke in their pathogenesis. Methods We collected serum samples fro...

Full description

Bibliographic Details
Main Authors: Jing Wang, Hong Liu, Zhenzhen Wang, Qing Pan, Furen Zhang
Format: Article
Language:English
Published: Sociedade Brasileira de Dermatologia 2023-04-01
Series:Anais Brasileiros de Dermatologia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962023000100013&lng=en&tlng=en
_version_ 1797852850261327872
author Jing Wang
Hong Liu
Zhenzhen Wang
Qing Pan
Furen Zhang
author_facet Jing Wang
Hong Liu
Zhenzhen Wang
Qing Pan
Furen Zhang
author_sort Jing Wang
collection DOAJ
description Abstract Background Significant association between bullous pemphigoid (BP) and stroke has been reported. This study aimed to evaluate the level of anti-BP180 antibody in stroke patients to explore the relationship between BP and stroke in their pathogenesis. Methods We collected serum samples from stroke patients and matched controls between February 2019 and June 2020. The anti-BP180 antibody levels were measured by enzyme-linked immunosorbent assay (ELISA). Results A total of 1183 stroke patients including 970 with cerebral infarction (CI), 192 with intracerebral hemorrhage (ICH), 21 with CI and ICH, and 855 controls were enrolled in this study. Anti-BP180 autoantibody values were significantly higher in stroke patients than in controls (p < 0.001). Anti-BP180 autoantibody-positive rates were 12.51% (148) in stroke patients and 4.68% (40) in controls (p < 0.001, OR = 2.65). In anti-BP180 autoantibody-positive subjects, the values were significantly higher in stroke patients than in controls (p < 0.001). However, only 10 (6.76%) stroke patients and 3 (7.5%) controls had high values (> 100 RU/mL) (p = 0.87). Stratified analysis showed that anti-BP180 antibody positive rates were independent of age, sex, and stroke subtypes in the stroke group. Positive rates in patients with both CI and ICH were nearly two times higher than those in patients with either CI or ICH alone (p = 0.11, OR = 1.94). Study limitations This study had a limited sample size and lacked quantitative criteria for stroke severity. Conclusions Anti-BP180 antibody values and positive rates were higher in stroke patients than in controls, suggesting that stroke patients may have higher of developing BP.
first_indexed 2024-04-09T19:40:58Z
format Article
id doaj.art-58c40d6d8be843869fb9f3ac3dc68ea5
institution Directory Open Access Journal
issn 0365-0596
language English
last_indexed 2024-04-09T19:40:58Z
publishDate 2023-04-01
publisher Sociedade Brasileira de Dermatologia
record_format Article
series Anais Brasileiros de Dermatologia
spelling doaj.art-58c40d6d8be843869fb9f3ac3dc68ea52023-04-04T07:34:46ZengSociedade Brasileira de DermatologiaAnais Brasileiros de Dermatologia0365-05962023-04-01981131610.1016/j.abd.2022.01.012Analysis of the autoimmune response to BP180 in Chinese stroke patientsJing Wanghttps://orcid.org/0000-0002-9894-1575Hong Liuhttps://orcid.org/0000-0003-4488-0372Zhenzhen Wanghttps://orcid.org/0000-0001-5927-2471Qing Panhttps://orcid.org/0000-0003-0112-4972Furen Zhanghttps://orcid.org/0000-0002-3383-1973Abstract Background Significant association between bullous pemphigoid (BP) and stroke has been reported. This study aimed to evaluate the level of anti-BP180 antibody in stroke patients to explore the relationship between BP and stroke in their pathogenesis. Methods We collected serum samples from stroke patients and matched controls between February 2019 and June 2020. The anti-BP180 antibody levels were measured by enzyme-linked immunosorbent assay (ELISA). Results A total of 1183 stroke patients including 970 with cerebral infarction (CI), 192 with intracerebral hemorrhage (ICH), 21 with CI and ICH, and 855 controls were enrolled in this study. Anti-BP180 autoantibody values were significantly higher in stroke patients than in controls (p < 0.001). Anti-BP180 autoantibody-positive rates were 12.51% (148) in stroke patients and 4.68% (40) in controls (p < 0.001, OR = 2.65). In anti-BP180 autoantibody-positive subjects, the values were significantly higher in stroke patients than in controls (p < 0.001). However, only 10 (6.76%) stroke patients and 3 (7.5%) controls had high values (> 100 RU/mL) (p = 0.87). Stratified analysis showed that anti-BP180 antibody positive rates were independent of age, sex, and stroke subtypes in the stroke group. Positive rates in patients with both CI and ICH were nearly two times higher than those in patients with either CI or ICH alone (p = 0.11, OR = 1.94). Study limitations This study had a limited sample size and lacked quantitative criteria for stroke severity. Conclusions Anti-BP180 antibody values and positive rates were higher in stroke patients than in controls, suggesting that stroke patients may have higher of developing BP.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962023000100013&lng=en&tlng=enAntibodiesBullous pemphigoidStroke
spellingShingle Jing Wang
Hong Liu
Zhenzhen Wang
Qing Pan
Furen Zhang
Analysis of the autoimmune response to BP180 in Chinese stroke patients
Anais Brasileiros de Dermatologia
Antibodies
Bullous pemphigoid
Stroke
title Analysis of the autoimmune response to BP180 in Chinese stroke patients
title_full Analysis of the autoimmune response to BP180 in Chinese stroke patients
title_fullStr Analysis of the autoimmune response to BP180 in Chinese stroke patients
title_full_unstemmed Analysis of the autoimmune response to BP180 in Chinese stroke patients
title_short Analysis of the autoimmune response to BP180 in Chinese stroke patients
title_sort analysis of the autoimmune response to bp180 in chinese stroke patients
topic Antibodies
Bullous pemphigoid
Stroke
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962023000100013&lng=en&tlng=en
work_keys_str_mv AT jingwang analysisoftheautoimmuneresponsetobp180inchinesestrokepatients
AT hongliu analysisoftheautoimmuneresponsetobp180inchinesestrokepatients
AT zhenzhenwang analysisoftheautoimmuneresponsetobp180inchinesestrokepatients
AT qingpan analysisoftheautoimmuneresponsetobp180inchinesestrokepatients
AT furenzhang analysisoftheautoimmuneresponsetobp180inchinesestrokepatients